Vigil Neuroscience Stock Buy Hold or Sell Recommendation
| VIGL Stock | USD 3.16 0.06 1.86% |
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Vigil Neuroscience is 'Strong Sell'. Macroaxis provides Vigil Neuroscience buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VIGL positions. The advice algorithm takes into account all of Vigil Neuroscience's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Vigil Neuroscience's buy or sell advice are summarized below:
Real Value 7.2 | Target Price 19.88 | Hype Value 3.12 | Market Value 3.16 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Vigil Neuroscience given historical horizon and risk tolerance towards Vigil Neuroscience. When Macroaxis issues a 'buy' or 'sell' recommendation for Vigil Neuroscience, the advice is generated through an automated system that utilizes algorithms and statistical models.
Vigil |
Execute Vigil Neuroscience Buy or Sell Advice
The Vigil recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vigil Neuroscience. Macroaxis does not own or have any residual interests in Vigil Neuroscience or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vigil Neuroscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Vigil Neuroscience Trading Alerts and Improvement Suggestions
| Vigil Neuroscience had very high historical volatility over the last 90 days | |
| Vigil Neuroscience has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (82.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vigil Neuroscience currently holds about 148.91 M in cash with (70.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Vigil Neuroscience has a frail financial position based on the latest SEC disclosures | |
| Over 86.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Vigil Neuroscience GAAP EPS of -0.57 in-line |
Vigil Neuroscience current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vigil analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vigil analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Vigil Neuroscience Returns Distribution Density
The distribution of Vigil Neuroscience's historical returns is an attempt to chart the uncertainty of Vigil Neuroscience's future price movements. The chart of the probability distribution of Vigil Neuroscience daily returns describes the distribution of returns around its average expected value. We use Vigil Neuroscience price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vigil Neuroscience returns is essential to provide solid investment advice for Vigil Neuroscience.
| Mean Return | 0.04 | Value At Risk | -6.37 | Potential Upside | 9.18 | Standard Deviation | 5.60 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vigil Neuroscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Vigil Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Vigil Neuroscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vigil Neuroscience backward and forwards among themselves. Vigil Neuroscience's institutional investor refers to the entity that pools money to purchase Vigil Neuroscience's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Orbimed Advisors, Llc | 2023-12-31 | 448.9 K | Geode Capital Management, Llc | 2023-12-31 | 315.5 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2023-12-31 | 289.5 K | State Street Corporation | 2023-12-31 | 283.3 K | Ensign Peak Advisors Inc | 2023-12-31 | 228.7 K | Anson Funds Management Lp | 2023-12-31 | 207 K | Trustees Of Columbia University In The City Of New York | 2023-12-31 | 193 K | Goldman Sachs Group Inc | 2023-12-31 | 170.2 K | Northern Trust Corp | 2023-12-31 | 141.4 K | Northpond Ventures, Llc | 2023-12-31 | 4.2 M | Citadel Advisors Llc | 2023-09-30 | 2.2 M |
Vigil Neuroscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vigil Neuroscience or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vigil Neuroscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vigil stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.11 | |
β | Beta against NYSE Composite | 2.77 | |
σ | Overall volatility | 5.67 | |
Ir | Information ratio | -0.0035 |
Vigil Neuroscience Volatility Alert
Vigil Neuroscience exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Vigil Neuroscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Vigil Neuroscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Vigil Neuroscience Fundamentals Vs Peers
Comparing Vigil Neuroscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vigil Neuroscience's direct or indirect competition across all of the common fundamentals between Vigil Neuroscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vigil Neuroscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vigil Neuroscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vigil Neuroscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Vigil Neuroscience to competition |
| Fundamentals | Vigil Neuroscience | Peer Average |
| Return On Equity | -0.54 | -0.31 |
| Return On Asset | -0.33 | -0.14 |
| Current Valuation | 12.47 M | 16.62 B |
| Shares Outstanding | 36.88 M | 571.82 M |
| Shares Owned By Insiders | 9.32 % | 10.09 % |
| Shares Owned By Institutions | 85.64 % | 39.21 % |
| Number Of Shares Shorted | 987.93 K | 4.71 M |
| Price To Book | 1.02 X | 9.51 X |
| EBITDA | (88.47 M) | 3.9 B |
| Net Income | (82.64 M) | 570.98 M |
| Cash And Equivalents | 148.91 M | 2.7 B |
| Cash Per Share | 5.27 X | 5.01 X |
| Total Debt | 13.85 M | 5.32 B |
| Debt To Equity | 0 % | 48.70 % |
| Current Ratio | 21.35 X | 2.16 X |
| Book Value Per Share | 3.24 X | 1.93 K |
| Cash Flow From Operations | (70.36 M) | 971.22 M |
| Short Ratio | 8.68 X | 4.00 X |
| Earnings Per Share | (2.13) X | 3.12 X |
| Target Price | 16.75 | |
| Number Of Employees | 69 | 18.84 K |
| Beta | 1.78 | -0.15 |
| Market Capitalization | 116.56 M | 19.03 B |
| Total Asset | 140.86 M | 29.47 B |
| Retained Earnings | (222.77 M) | 9.33 B |
| Working Capital | 110.25 M | 1.48 B |
| Net Asset | 140.86 M |
Note: Insider Trading [view details]
Vigil Neuroscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vigil . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Vigil Neuroscience Buy or Sell Advice
When is the right time to buy or sell Vigil Neuroscience? Buying financial instruments such as Vigil Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 116K | 9.2M | 8.8M | 5.2M | Total Assets | 102.4M | 200.4M | 140.9M | 129.0M |
Use Investing Ideas to Build Portfolios
In addition to having Vigil Neuroscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Housewares Thematic Idea Now
Housewares
Companies making housewares accessories and providing houseware services. The Housewares theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Housewares Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Vigil Neuroscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.Note that the Vigil Neuroscience information on this page should be used as a complementary analysis to other Vigil Neuroscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Vigil Stock analysis
When running Vigil Neuroscience's price analysis, check to measure Vigil Neuroscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vigil Neuroscience is operating at the current time. Most of Vigil Neuroscience's value examination focuses on studying past and present price action to predict the probability of Vigil Neuroscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vigil Neuroscience's price. Additionally, you may evaluate how the addition of Vigil Neuroscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Vigil Neuroscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.13) | Return On Assets (0.33) | Return On Equity (0.54) |
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.